IE40794B1 - Influenza vaccines - Google Patents

Influenza vaccines

Info

Publication number
IE40794B1
IE40794B1 IE59/75A IE5975A IE40794B1 IE 40794 B1 IE40794 B1 IE 40794B1 IE 59/75 A IE59/75 A IE 59/75A IE 5975 A IE5975 A IE 5975A IE 40794 B1 IE40794 B1 IE 40794B1
Authority
IE
Ireland
Prior art keywords
influenza
components
virus
type
cationic detergent
Prior art date
Application number
IE59/75A
Other languages
English (en)
Other versions
IE40794L (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE40794L publication Critical patent/IE40794L/xx
Publication of IE40794B1 publication Critical patent/IE40794B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
IE59/75A 1974-01-14 1975-01-13 Influenza vaccines IE40794B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (enExample) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
IE40794L IE40794L (en) 1975-07-14
IE40794B1 true IE40794B1 (en) 1979-08-15

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
IE59/75A IE40794B1 (en) 1974-01-14 1975-01-13 Influenza vaccines

Country Status (27)

Country Link
JP (2) JPS58407B2 (enExample)
AT (1) AT345449B (enExample)
AU (1) AU500250B2 (enExample)
BE (1) BE824372A (enExample)
CA (1) CA1049406A (enExample)
CH (1) CH589453A5 (enExample)
CS (1) CS191254B2 (enExample)
DD (1) DD116239A5 (enExample)
DE (1) DE2500785B2 (enExample)
DK (1) DK140003B (enExample)
ES (1) ES433759A1 (enExample)
FI (1) FI54053C (enExample)
FR (1) FR2257305B1 (enExample)
GB (1) GB1498261A (enExample)
HK (1) HK56380A (enExample)
HU (1) HU173920B (enExample)
IE (1) IE40794B1 (enExample)
IL (1) IL46426A (enExample)
MY (1) MY8100204A (enExample)
NL (1) NL166622C (enExample)
NO (1) NO143128C (enExample)
PH (1) PH14458A (enExample)
PL (1) PL93689B1 (enExample)
SE (1) SE427238B (enExample)
SU (1) SU616997A3 (enExample)
YU (1) YU41289B (enExample)
ZA (1) ZA75259B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
ES2525518T3 (es) * 2005-11-01 2014-12-26 Novartis Vaccines And Diagnostics Gmbh Vacunas virales derivadas de células con niveles reducidos de ADN celular residual
EP2192917B1 (en) * 2007-08-28 2014-01-29 Baxter International Inc. Method for producing viral vaccines
JP6373376B2 (ja) 2013-11-15 2018-08-15 ノバルティス アーゲー 残留細胞培養不純物の除去

Also Published As

Publication number Publication date
FI54053C (fi) 1978-10-10
DK1475A (enExample) 1975-09-01
CS191254B2 (en) 1979-06-29
AU7730575A (en) 1976-07-15
IE40794L (en) 1975-07-14
JPS58407B2 (ja) 1983-01-06
SU616997A3 (ru) 1978-07-25
CA1049406A (en) 1979-02-27
AT345449B (de) 1978-09-11
FI54053B (fi) 1978-06-30
YU5875A (en) 1984-04-30
CH589453A5 (enExample) 1977-07-15
NL166622C (nl) 1981-09-15
NO750031L (enExample) 1975-08-11
NO143128B (no) 1980-09-15
NL7500301A (nl) 1975-07-16
ES433759A1 (es) 1977-02-16
DD116239A5 (enExample) 1975-11-12
DE2500785B2 (de) 1980-01-03
GB1498261A (en) 1978-01-18
BE824372A (fr) 1975-07-14
JPS50100224A (enExample) 1975-08-08
ATA21475A (de) 1978-01-15
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
FR2257305A1 (enExample) 1975-08-08
HK56380A (en) 1980-10-16
JPS6035326B2 (ja) 1985-08-14
PL93689B1 (enExample) 1977-06-30
JPS56127319A (en) 1981-10-06
DE2500785A1 (de) 1975-07-31
DK140003C (enExample) 1979-10-29
AU500250B2 (en) 1979-05-17
DE2500785C3 (enExample) 1980-09-11
FI750014A7 (enExample) 1975-07-15
IL46426A0 (en) 1975-04-25
MY8100204A (en) 1981-12-31
HU173920B (hu) 1979-09-28
IL46426A (en) 1978-01-31
DK140003B (da) 1979-06-05
PH14458A (en) 1981-07-29
YU41289B (en) 1987-02-28
NL166622B (nl) 1981-04-15
FR2257305B1 (enExample) 1982-03-19
SE427238B (sv) 1983-03-21
SE7500130L (enExample) 1975-07-15

Similar Documents

Publication Publication Date Title
Haslam et al. The structural proteins of Newcastle disease virus
IE40794L (en) Influenza vaccine.
KR850001700A (ko) 단순 헤르페스 바이러스 서브유니트 왁진(Herpes Simplex Virus Subuait Vaccine)의 제조방법
Lahelle et al. Hemagglutination with the GDVII strain of mouse encephalomyelitis virus
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
Hirst et al. A new method for concentrating influenza virus from allantoic fluid
Bang Filamentous forms of Newcastle virus
CA2503774C (en) Improvements in virus production
Wilcox et al. Soluble Antigens of Vaccinia-infected Mammalian Cells II. Time Course of Synthesis of Soluble Antigens and Virus Structural Proteins
GB2001326A (en) Glycoproteins from paramyxovirus and vaccines therefrom
ES430415A1 (es) Un procedimiento para preparar una vacuna de virus de la gripe atenuado.
Mims Rift Valley fever virus in mice. II. Adsorption and multiplication of virus
GB1488800A (en) Influenza vaccines
GB660109A (en) Improvements in or relating to the treatment of allantoic fluid containing a propagated virus together with non-viral proteins to obtain the virus in purified and viable from for use in a vaccine
GB1016586A (en) Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis
IE830861L (en) Equine influenza vaccine.
GB1327870A (en) Process for the manufacture of a vaccine against infectious bursitis of chickens
JP2841592B2 (ja) ウイルス粒子の破砕法
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
Greer et al. Electron microscope study of the interaction of vaccinia virus with macrophages from immunized and nonimmunized rabbits
EP0374817A3 (en) Method for disrupting virus particles
WO2024186901A3 (en) Broadly reactive immunogens of influenza h3 virus, compositions and methods of use thereof
郭元吉 et al. Influenza C virus isolated from pigs in China
GB1481650A (en) Chemical processes and products
ES379053A3 (es) Procedimiento de preparacion de vacunas antiviricas.